Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar;1879(2):189079.
doi: 10.1016/j.bbcan.2024.189079. Epub 2024 Jan 26.

VEGF signaling: Role in angiogenesis and beyond

Affiliations
Review

VEGF signaling: Role in angiogenesis and beyond

Pallab Shaw et al. Biochim Biophys Acta Rev Cancer. 2024 Mar.

Abstract

Angiogenesis is a crucial process for tissue development, repair, and tumor survival. Vascular endothelial growth factor (VEGF) is a key driver secreted by cancer cells, promoting neovascularization. While VEGF's role in angiogenesis is well-documented, its influence on the other aspects in tumor microenvironemt is less discussed. This review elaborates on VEGF's impact on intercellular interactions within the tumor microenvironment, including how VEGF affects pericyte proliferation and migration and mediates interactions between tumor-associated macrophages and cancer cells, resulting in PDL-1-mediated immunosuppression and Nrf2-mediated epithelial-mesenchymal transition. The review discusses VEGF's involvement in intra-organelle crosstalk, tumor metabolism, stemness, and epithelial-mesenchymal transition. It also provides insights into current anti-VEGF therapies and their limitations in cancer treatment. Overall, this review aims to provide a thorough overview of the current state of knowledge concerning VEGF signaling and its impact, not only on angiogenesis but also on various other oncogenic processes.

Keywords: Angiogenesis; Anti-VEGF therapies; Intercellular crosstalk; Intra-organelle crosstalk; Tumor microenvironment; VEGF-VEGFR.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no known competing financial or personal interests that could have appeared to influence the manuscript.

Similar articles

Cited by

References

Publication types

Substances

LinkOut - more resources